Dechra Pharmaceuticals PLCDPH:LSE

1,013
2.00 / 0.20 %
122.68k
50.63%
0.3606
Close in GBXToday's changeShares traded1 year changeBeta
Data delayed at least 15 minutes, as of Mar 27 2015 17:15 GMT.

Summary

On Friday, Dechra Pharmaceuticals PLC (DPH:LSE) closed at 1,013, 2.78 % below its 52-week high of 1,042, set on Mar 25, 2015.

52-week range
Today
655.00
Apr 23 2014
1,042
Mar 25 2015
Markit short selling activity
Low
Medium
High
Open1,017
Day high--
Day low--
Bid--
Offer--
Previous close1,013
Average volume127.15k
Shares outstanding87.95m
Free float84.77m
P/E (TTM)40.23
Market cap890.94m GBP
EPS (TTM)0.2518 GBP
Annual div (IAD)15.77 GBX
Annual div yield (IAD)1.56%
Div ex-dateMar 12 2015
Div pay-dateApr 07 2015
Data delayed at least 15 minutes, as of Mar 27 2015 17:15 GMT.
Last IC View
The last IC recommendation on Dechra Pharmaceuticals PLC shares was Hold at 925.00 on 24 Feb 2015
Read the full article

Comparative analysis

Past 90 days
1 week1 month6 months1 year5 years
Dechra Pharmaceuticals PLC-1.94 %+8.63 %+33.64 %+50.63 %+167.35 %
FTSE 100 Index-2.39 %-1.32 %+3.09 %+4.05 %+20.20 %
Data delayed at least 15 minutes, as of Mar 27 2015 17:15 GMT.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.